Introduction

Erdheim-Chester Disease is an extremely rare form of blood cancer in which histiocytes, white blood cells which are essential for immunity against diseases, multiply uncontrollably. These excess histiocytes move to parts of the body where they are not usually found, damaging organs and eventually causing organ failure.¹ 

Awareness of Erdheim-Chester disease helps individuals recognise the disease early - allowing for early and effective treatment. Seeking medical attention early also helps patients make informed decisions about their health and treatment. As such, this article aims to help you understand the causes, symptoms, diagnosis, and management of Erdheim-Chester disease.

Understanding the disease

Certain genetic factors, environmental exposures, or autoimmune mechanisms can cause histiocytes to begin to multiply limitlessly. These excess cells travel to different parts of the body, including the bones, heart, lungs, kidneys, brain and spinal cord.

Histiocytes release inflammatory mediators - chemicals that normally play an important role in the immune response to injury and infection. However, in Erdheim-Chester disease, the prolonged release of these inflammatory chemicals causes damage to cells of your body, rather than a foreign organism - and eventually causes tissue damage and organ failure.²

Common damage observed in Erdheim-Chester disease include:^3,5

• Bone fractures
• Distorted bone size or shape
• Holes within bones
• Swelling of the eye socket
• Deterioration of the optic nerve
• Dry and itchy patches on the skin
• Narrowing of blood vessels supplying the heart muscle 
• Breakdown of the heart muscle
• Increased fluid in the brain
• Breakdown of the protective covering of nerve fibres 
• Compression of airways
• The buildup of fluid between the lungs and chest wall
• Hardening of lung tissues
• Compression of blood vessels in the liver and scarring of liver tissue

Epidemiology of erdheim-chester disease

Erdheim-Chester is a rare disease, with only ~1000 cases having been reported to date.⁶ The disease can affect anyone regardless of age, gender, or ethnicity. However, general trends indicate that:⁶

• Erdheim-Chester disease is most common in adults between the ages of 40 and 60
• Erdheim-Chester disease is more commonly seen in Caucasians than in any other ethnic groups
• Erdheim-Chester disease is more prevalent in individuals assigned male at birth 

These statistics should not discourage you from seeking medical attention or from seeking out professional help if you are experiencing symptoms associated with ECD.

What causes erdheim-chester disease?

The rarity of this disease has significantly limited research, meaning that we do not yet know exactly what causes Erdheim-Chester disease. However, the primary causes are thought to be genetic mutations. 

Mutations to the BRAF V600E gene have been observed in most Erdheim-Chester patients. This mutation increases the multiplication rate and longevity of histiocytes, allowing them to accumulate within the body.²

Other genes associated with Erdheim-Chester disease include MAP2K1, NRAS, KRAS and PI3KCA. These are all thought to encourage cell growth and survival.²

These mutations are somatic (meaning they appear during a person’s lifetime) and are not passed down from parents to children or from person to person, meaning that Erdheim-Chester disease is not inherited or contagious.²

Symptoms of erdheim-chester disease

The symptoms and signs of Erdheim-Chester depend on the progression of the disease and its location within the body. However, possible symptoms include:⁷

• Pain in the lower legs and upper arms  
• Pain or strain when urinating
• Irregular heartbeat
• Heart failure 
• Itchy, dry or scaly skin with red or purple spots
• Eye pain
• Vision problems
• Frequent and unusual headaches
• Sudden onset of seizures
• Problems with coordination and balance
• Slurred speech
• Trouble with focus and memory
• Shortness of breath or chest pain
• Fever
• Night sweats
• Weight loss

Diagnosis

You may have noted that many of the symptoms listed above are fairly common in individuals over the age of 40 - and you would be spot on. 

The rarity and varied symptoms of Erdheim-Chester disease mean that healthcare providers do not suspect or consider it. Further, mavery few physicians have first-hand experience treating Erdheim-Chester disease. Consequently, many cases remain undiagnosed. 

If your doctor suspects you have Erdheim-Chester disease, a combination of extensive tests and evaluations is essential to confirm a diagnosis. These include:

• Physical examination: looking for bone pain, skin rashes, vision problems, and slurred speech, and assessing focus and recall
• Blood tests: to check for increased histiocyte count and levels of other enzymes and chemicals.
• Imaging studies: X-rays, CT scans, and MRI scans can help identify the location and progression of lesions or tumours caused by Erdheim-Chester disease
• Bone biopsies: these can be performed to detect and identify abnormal histiocytes microscopically
• Genetic testing: this can help detect specific genetic mutations that are known to cause ECD³

How is erdheim-chester disease treated?

If, at the time of diagnosis, Erdheim-Chester disease is not negatively affecting your body, your healthcare professional may choose to just monitor it.⁸ While there is no cure for ECD, its symptoms can be managed to improve the quality of your life. Some of the options include:

• Targeted therapy: targeted therapy drugs slow the progression of Erdheim-Chester disease in most organs (but not the brain and spinal cord). These drugs target the gene mutations that cause histiocytes to divide uncontrollably. The BRAF V600E mutation can be treated with vemurafenib, dabrafenib or encorafenib. The MAP2K1, NRAS, KRAS, and PI3KCA mutations can be managed using cobimentinib, binimetinib, and trametinib, which are available in pill form⁸
• Chemotherapy and radiotherapy: these approaches are widely used to treat cancers. Chemotherapy drugs used for Erdheim-Chester include cladribine and methotrexate, which can be administered intravenously under medical supervision.⁷ Radiation therapy is used to destroy cancer cells non-invasively
• Immunotherapy: has been previously used to treat Erdheim-Chester by suppressing the immune system’s response to the excess histiocytes⁷
• Biological therapy: this treatment suppresses the inflammatory mediators released by histiocytes, preventing inflammation and reducing damage to organs. Studies show that the biological therapy anakinra can be used to treat Erdheim-Chester⁷
• Surgery: surgery may be used to remove inflamed or damaged tissue, reconstruct damaged or fractured bones, correct vision problems, or relieve pressure caused by fluid buildup. These can all help improve a patient’s quality of life⁸
• Corticosteroids: these drugs alter the immune system’s normal responses to reduce swelling and pain in the eyes, bones, and skin⁷

Living with erdheim-chester disase

Erdheim-Chester disease can cause a variety of symptoms. However, the severity and impact of these symptoms vary greatly from person to person, making it a very challenging experience to predict how the disease will affect an individual in the long term.

The physical symptoms of Erdheim-Chester, like bone pain, skin rashes, vision problems, chest pain, and the loss of focus and memory can significantly lower a patient’s quality of life. The treatment for the many symptoms can be complex, involving multiple surgeries and medications that can be stressful, time-consuming, and expensive.

Being diagnosed with an incurable and physically limiting disease can be mentally taxing. Many individuals may develop feelings of anxiety or depression. The financial burden of medications and medical procedures and the time required for treatment also add to this mental burden. It may become difficult to live life as other healthy individuals participate in activities normally and maintain relationships with others as before, leading to feelings of loneliness.

Despite these challenges, it is important to remember that many people with Erdheim-Chester disease live happy and fulfilling lives empowered by proper disease management and support. As such, if you or your loved one is diagnosed with Erdheim-Chester, it is important to seek medical intervention immediately to halt the progression of the disease and begin planning management strategies. Accommodating their new physical disability to make their lives easier and supporting them through various medical procedures goes a long way in helping them accept their new reality.

Summary

Erdheim-Chester disease is a rare type of blood cancer characterised by the abnormal multiplication and accumulation of histiocytes, a type of white blood cell. These histiocytes invade various tissues and organs, leading to inflammation, tissue damage and various symptoms.

Key points about Erdheim-Chester disease:

• Causes: the exact cause is unknown, but it is thought to be an autoimmune disorder with genetic and environmental factors playing a role.
• Symptoms: symptoms can vary widely depending on the affected organs. Common symptoms include bone pain, skin rashes, eye problems, heart problems, lung problems, and a decline in focus and memory.
• Diagnosis: diagnosis involves a combination of physical examination, blood tests, imaging studies, bone biopsy, and genetic testing.
• Treatment: treatment options include targeted therapies, chemotherapy, radiation therapy, surgery, corticosteroids, and supportive care measures.
• Research: ongoing research is focused on understanding the disease better, developing new diagnostic tools, and exploring new treatment options.

While Erdheim-Chester disease can be a challenging condition, advancements in research and treatment offer hope for improved outcomes. If you or someone you know is experiencing symptoms indicative of ECD, it's crucial to seek medical advice for proper diagnosis and management.

Resources and additional information

• Connect with other individuals
• Learn more about Erdheim-Chester Disease
• Learn and take part in clinical trials for ECD